Meet The Team
Reshaping diabetes care
We are not just a company. We are a close-knit family of problem solvers dedicated to resolving the challenges people with diabetes face every day.
Board of Directors
Dean Kamen
Co-Founder & Director
Dean is the Co-Founder of Sequel and the original inventor of the first wearable insulin infusion pump. He has decades of experience as an entrepreneur and innovator, creating a variety of devices and robotics that improve people's lives. Dean leads a team of ~1,000 technical professionals at DEKA.
Pablo Legorreta
Co-Founder & Director
Pablo is the Co-Founder of Sequel, and the Founder, CEO, and Chairman of Royalty Pharma plc., the market leader in royalty funding of life science innovation. Pablo is also the co-founder of numerous companies dedicated to improving the lives of people with chronic kidney disease.
Alan Lotvin
CEO / Co-Founder & Director
Alan is a senior healthcare executive with over 30 years experience from CVS Health ® and CVS Caremark ®, ICORE Healthcare, and Medco Health Solutions. He is a clinician and cardiologist by training. Alan is a director at ProKidney.
Maureen Toohey
Co-Founder & Director
Maureen is an accomplished attorney with over 25 years of experience in private practice and in the medical device industry. Currently, she is the Managing Member of The Toohey Law Group LLC, and the Deputy Executive Director of Advanced Regenerative Manufacturing Institute (ARMI).
William Doyle
Co-Founder & Director
Bill has more than 30 years of experience in the medical device and biotechnology industries. He serves as the Executive Chairman at Novocure; a Director at Elanco Animal Health; a Director at Minerva Neurosciences; and a Director at ProKidney. Bill previously held management positions at Johnson & Johnson and McKinsey & Company.
Executive Leadership
Beth Keyt
SVP, Sales, Market Access, and Government Affairs
Beth serves as Sequel's Senior Vice President of Sales, Market Access, and Government Affairs. Beth has over 25 years of experience in the medical device and digital healthcare space, including Dexcom and Johnson & Johnson, where she focused on innovative devices for diabetes care.
Jennifer LeBlanc, MBA, BS, RN, CDCES
VP, Clinical Strategy
Jennifer has over 25 years of combined clinical, research, industry, and leadership experience, focused on diabetes. She previously was at the Joslin Diabetes Center in Boston, MA, where she spearheaded a team that led innovations in education and consulting, globally. Jennifer was the ADCES's recipient of the "Innovative Use of Technology Award" in 2019.
Stella Zhou
VP, Commercial Product & Patient Experience
Stella has over 15 years of experience bringing products to market, with a focus on the patient experience in diabetes care. She has successfully commercialized healthcare products at companies ranging from early-stage VC/PE-backed to Fortune 5. Stella began her career at McKinsey & Company and Procter & Gamble.
Simona Jantz, MSc
VP, Quality
Simona is a Quality, Regulatory and Compliance executive with more than 10 years in the Medical Device Industry. She has helped organizations create highly compliant processes while propelling culture shifts with Lean and Six Sigma principles implementations. She holds awards from the National Science Research Council of Canada.
Scott McBride
VP, Technology & Operations
Scott is an experienced technology executive with leadership roles at Google and Microsoft. His background includes over a decade in cloud computing and data science strategy & execution. He also served as an officer in the US Navy.
Quraish Baldiwala
VP, Global Supply Chain
Quraish has held leadership roles in Supply Chain, Operations, and Commercial at Gillette, General Mills, and Abbott Laboratories. A proven entrepreneur, he has a B.Eng. from University of Mumbai, and both an MBA in Supply Chain & International Business and an MS in Operations Management from University of Wisconsin-Madison. He's also a board member for non-profits, global coach, mentor, and an aspiring epicurean.